Roche Diagnostics deploys Endotrophin research assay at Nordic Bioscience
Roche Diagnostics has integrated its Endotrophin prototype immunoassay onto the cobas e801 analyzer platform at the Nordic Bioscience CLIA-certified laboratory.

Roche Diagnostics has moved to broaden the reach of its Endotrophin (ETP) research prototype by installing the assay on its cobas e801 analyzer systems located at Nordic Bioscience's CLIA-certified laboratory in Herlev, Denmark.
The Endotrophin assay, a sandwich immunoassay, is designed for the quantification of ETP, a protein fragment associated with collagen VI and linked to various fibrotic conditions. By enabling this test on the cobas e801 platform, the companies intend to streamline the measurement process for researchers studying extracellular matrix turnover.
This deployment allows Nordic Bioscience to utilize automated diagnostic hardware for specialized research applications. The initiative focuses on scaling the ability to analyze biological samples with higher throughput compared to manual research methods, addressing a niche requirement in fibrosis biomarker development.
The collaboration marks a step in the application of standard clinical diagnostic equipment for specific research-grade biomarker assessments.